DOCTORS PANEL QUESTIONS & ANSWERS

DOCTORS PANEL QUESTIONS & ANSWERS


 


We wish to thank all the members on our Doctors Panel, for giving us their
time answering PBCers questions.  We greatly appreciate all they do for us.

The following questions were answered by: 
Melissa Palmer, M.D.
Specialty: Gastroenterology and Hepatology 
Private Practice Long Island, NY
Author of "Guide to Hepatitis & Liver Disease" revised edition which was
published in June 2004.  http://www.liverdisease.com/

Dr. Palmer will be one of our guest speakers at the 2005 conference in
Las
Vegas
.

2004


QUESTION 1
Is arthritis one of the effects of the PBC or is it a natural occurrence
because of the ages of most patients?
I take Vioxx for arthritis. Is this safe or at-risk to liver


ANSWER 1
Rheumatoid arthritis, which is characterized by joint aches and joint
deformities, can be seen with an increased incidence in people with PBC. Since many
rheumatologic disorders - such as arthritis, have an autoimmune origin, it is
not surprising that there is a high degree of association between all
rheumatologic disorders -including arthritis, and PBC.

Women in general, with or without PBC, have a higher incidience of arthritis
than men.  Since PBC is primarily a disease that affects women, arthritis
often occurs.  Systemic lupus erythematosus (SLE) may also occur in people with
PBC and is characterized by fever, skin rash, and arthritis.

Acetylsalicylic acid (aspirin) and other NSAIDs are drugs that are widely
used for their anti-inflammatory and analgesic effects. They also have the
potential to cause drug-induced liver disease. In fact, many NSAIDs have been
withdrawn from the market due to their hepatotoxicity. All NSAIDs have the potential
to cause liver injury. However, some NSAIDs are more hepatotoxic than others.
NSAIDs presently on the market that have been frequently associated with
liver injury are aspirin (ASA), diclofenac (Voltaren), and sulindac (Clinoril).
Ibuprofen (Motrin) has been reported to cause severe liver injury in people with
hepatitis C. A new generation of NSAIDs, known as the cyclooxygenase-2
(COX-2) inhibitors, has recently been approved by the FDA.  This group of NSAIDs has
the advantage of having fewer gastrointestinal side effects - less abdominal
discomfort and less risk of gastrointestinal bleeding, than conventional
NSAIDs. There are three different COX-2 inhibitors currently available to the
public-  Vioxx, Celebrex and Bextra.  COX-2 inhibitors have been associated with
some liver dysfunction, although not as commonly as other NSAIDs.

It is recommended that people with liver disease, especially those with stage
3 or 4 disease, avoid using all NSAIDs. If NSAIDs are medically required for
the treatment of another medical disorder, a reduced dose should be used for a
limited period of time and only by people with stable liver disease. Older
women with liver disease seem to be particularly susceptible to the
hepatotoxicity of NSAIDs and are advised to avoid NSAIDs altogether.  Since NSAIDs may
cause salt and water retention people with fluid retention problems such as
ascites or leg swelling may suffer worsening of these conditions.  People with
decompensated cirrhosis are at increased risk kidney damage stemming from the use
of NSAIDs. Since this may lead to hepatorenal syndrome, people with advanced
liver disease are advised to totally avoid all NSAIDs.  Furthermore, people
with ascites (fluid accumulation) may not respond to treatment with water pills
(diuretics), while on NSAIDs, as they counteract their actions. People with
liver disease who have had internal bleeding, - from an ulcer or esophageal
varices, for example, may be at risk for recurrent bleeding induced by NSAIDs, and
should totally avoid this class of medications. People who are also taking
corticosteroids (such as prednisone), or anticoagulants (such as coumadin) may
have and increased risk of complications from NSAIDs.  Finally, people with
liver disease who smoke cigarettes or drink alcohol should avoid NSAIDs as they
are also at increased risk for its complications.


QUESTION 2
What concerns and recommendations are there for a female PBC patient's use
Premarin (Oral and Vaginal Creme) ? 
Are PBC patients more likely to have breast cancer from the hormones?


ANSWER 2
The use of estrogen supplementation in people with liver disease is a
controversial issue that needs to be studied in more detail.    While
estrogen-hormonal therapy has been demonstrated to increase bone mass, oral estrogen
replacement should generally be avoided in people with liver disease - especially
those with PBC, as it may cause additional liver problems, such as worsening of
cholestasis. Furthermore, estrogen supplementation may cause certain benign
liver tumors, such as hemangiomas and/or hepatic adenomas to enlarge. Estrogen
patches and cremes are generally a safer choice.  Implantable estrogen, a recent
development, is probably safe, but long-term studies as to its effect on liver
disease have not been done. Soy estrogen, originally thought to be a safe
alternative, should be avoided, as recent reports have suggested that it may
cause drug-induced hepatitis. Finally, the use of estrogen has been cited as even
potentially triggering the autoimmune response that leads to the development
of PBC.

Some studies, although not all, have found an increased incidence of breast
cancer in people with PBC. However, since the likelihood that a person with PBC
will develop breast cancer is quite low, routine breast cancer
surveillance-more diligent than that recommended for the general populations- is not
mandatory.


QUESTION 3
Shortness of breath & fatigue
Can shortness of breath due to liver disease occur in earlier stages of PBC
or just stage 4?
I've talked to other PBCers and many of us get shortness of breath shopping,
walking, etc.
Can you explain the reason and give us recommendations?
As the PBC progresses does the fatigue and need of sleep increase, or could
this be due to something else?


ANSWER 3
Sarcoidosis is a disease characterized by the formation of granulomas
(nodules filled with a variety of inflammatory cells) in many organs including the
lungs, skin, liver, lymph nodes, and bones. This disease resembles primary
biliary cirrhosis (PBC) in that both diseases are characterized by the formation of
granulomas. PBC and sarcoidosis occasionally coexist together.  When
sarcoidosis affects the lungs, it may cause shortness of breath. However, the
shortness of breath that occurs in people with PBC is usually due to fatigue.

Fatigue is the most common symptom in people with PBC, occurring in
approximately 65 percent. The cause of fatigue in people with PBC is not known,
however, depression and sleep disorders may be contributing factors. The degree of
fatigue does not correlate with the severity of the disease and may be just as
debilitating for a person in an early stage of PBC as it is for a person in an
advanced stage of PBC. Question 4 below addresses the treatment of fatigue.


QUESTION 4
I know PBC is causing fatigue. I read that taking Coenzyme Q10 with
L-carnitine fumarate can help getting our energy back.  What about Provigil?
Is there any danger to the liver in taking these?


ANSWER 4
Successfully treating fatigue can be a challenge. In attempting to combat
fatigue, all of the possible causes of a person's fatigue should be looked into.
Some causes are easily managed. Some occur commonly in people with liver
disease. The potential causes of, and/or contributors to, fatigue include the
following:
o    Thyroid disease (may be primary cause of, or contribute to, fatigue).
o    Anemia (may be primary cause of, or contribute to, fatigue).
o    Disorders of other organs, including the heart (for example, congestive
heart failure) or the brain (for example, brain tumors).
o    Nutritional deficiencies (for example, a lack of iron or a lack of
protein).
o    Disturbances in fluid and electrolyte balance (for example, a low sodium
level).
o    Depression
o    Some medications and drugs (a doctor should review all prescription and
over-the-counter medications that a patient is taking.  If possible, those
that cause fatigue should be discontinued).
o    Excessive use of caffeine.
o    Excessive use of alcohol.
o    Emotional stress.
o    Lack of exercise.
o    Lack of sleep.
o    Overwork.

If fatigue continues to persist after ruling out or correcting any of the
above factors,  there are some lifestyle changes that may be helpful. For example
-  eating a healthy, low-fat, well-balanced diet; quitting smoking;
refraining from alcohol consumption; and exercising daily, are all lifestyle changes
that can ameliorate fatigue. Also it is recommended to drink plenty of water and
limit caffeine-containing beverages to one or two servings per day.

Never consume large heavy meals.  Four to six small meals throughout the day
will keep energy levels high, and will minimize fatigue.  It goes without
saying, but bears repeating anyway: people with liver disease should avoid
drinking alcohol. Alcohol can worsen any liver disease and is a cause of fatigue as
well. It's also a good idea when necessary, to begin a healthy weight-reducing
diet to eliminate any excess weight. (Never lose more than one to two pounds
per week).

The demands of a hectic job or harried home life may need to be
reduced-overwhelming stress may cause fatigue even in a person who is not suffering from
liver disease. Excessive stress, including emotional stress, is often the cause
of fatigue in people with liver disease. Therefore, friends and family should
attempt to reduce the normal load of obligations and expectations that they
may normally have had of the person.

If possible, a thirty to forty-five-minute daytime nap should be taken daily.
This can help rejuvenate a person with liver disease. In some cases, it may
be necessary for a person with liver disease to incorporate naps into her daily
schedule. Often, a doctor's letter to the patient's employer or supervisor
may be needed.  A person with fatigue should feel free to ask her doctor for
such a note.  If a daytime nap is impossible, try to do some mid-day exercises. 
When sitting at a desk job all day, for example, blood tends to move away from
the head and muscles.  This results in both mental and physical fatigue.  It
is important to get your blood circulating throughout your entire body. Try to
get up and walk around or simply do some stretching exercises.   Even a
little exercise will help get you concentrating and motivated again.

Remember, fatigue cannot be cured by a pill! Be especially wary of any
products that boast "improved energy levels" on their label. Because the liver is in
charge of breaking down all supplements and medications, more harm than good
may result from taking such  products. Also, be aware that taking excessive
amounts of vitamins and minerals in an attempt to combat fatigue-especially
vitamin A, niacin, and iron-can lead to a worsening of liver disease. Coenzyme Q
10 is vitamin-like antioxidant found in all parts of the body.  This substance
aids in the production of energy and stimulates the immune system.  It has
been used to reduce the side effects of cancer chemotherapy. Thus, it may be
helpful in reducing interferon-related side effects, although no studies have been
performed to assess its efficacy in this area. COQ 10 has been used to treat
allergic disorders, such as asthma, mental disease such as Alzheimer's and
heart disease. The amount of COQ 10 in one's body decreases with age. Therefore,
it is recommended that people over the age of 50  supplement their diets with
this substance. Deficiency of this substance may lead to tooth decay and
diabetes.  COQ 10 has been found to be effective at dosages ranging from 50 to 200
mg daily. Foods which are good sources of CoQ 10 include mackerel, salmon,
sardines, beef, peanuts and spinach.  I am not familiar with the use of
l-carnitine for people with liver disease. It is essential that a person with liver
disease consult a liver specialist prior to taking any supplements or products
that promise to cure fatigue.

Ondansetron (Zofran) is a medication used in the treatment of nausea and
vomiting associated with cancer chemotherapy.  There have been anecdotal reports
on the use of Zofran ( 4 mg twice a day) in the management of fatigue
associated with liver disease. Other medications have been found to be helpful in
treating fatigue associated with other  diseases such as HIV, melanoma and chronic
fatigue syndrome. These medication include bupropion (Wellbutrin),
methylphenidate (Ritalin), and modafinil (Provigil). Provigil is a medication approved
for the treatment of narcolepsy - a neurological disorder marked by
uncontrollable attacks of daytime sleepiness. Anecdotal evidence suggests that Provigil at
a dose of 200 mg/day may be a useful adjunct in the treatment of fatigue
associated with liver disease. More studies need to be conducted on patients with
liver disease before any of the above-mentioned medications can be  routinely
recommended for use in the  management of fatigue.


QUESTION 5
What substances should PBCers avoid such as cosmetics, perfumes, colors for
the hair, nails polish, home cleaning products?


ANSWER 5
There is no specific recommendations concerning the above products in people
with PBC.  However, it is important to have good ventilation available when
using home cleaning products or any products creating excessive fumes.


QUESTION 6
Is it possible that itching is caused by Urso treatment? I  had very little
itching prior to starting the urso.
I wonder if you've heard anything about a supplement SAMe being used for
treatment of PBC?


ANSWER 6
Pruritus occurs in approximately 80 percent of people with PBC, and its cause
is not entirely known. Any medication may cause itching, but most studies
have indicated that less than 3 percent of people develop adverse side effects
from Urso. When side effects from Urso are experienced, they include diarrhea,
decreased white blood cell count, elevated glucose levels, elevated creatinine
levels, peptic ulcers, and skin rashes (which also may cause itching).

SAMe is a derivative of the amino acid L-methionine. It is made in the body
when methionine combines with energy (adenosine triphosphate [ATP]). In
Europe,
SAMe is considered a drug to treat liver disease, fibromyalgia and
depression. SAMe may improve liver enzyme elevations and may reverse, or even prevent
liver toxicity which is caused by various drugs as well as alcohol and some
chemicals. It may increase natural levels of glutathione - an antioxidant enzyme
produced by the liver that protects the liver from free-radical damage.  And it
has also been postulated that SAMe may prevent liver tumors.  Further study
needs to be conducted with SAMe before it can be routinely recommended for
people with liver disease. In fact, studies using SAMe in people with PBC are
ongoing.  If used, dosages should not exceed  800 mg twice per day and should be
taken on an empty stomach.


 

 

 

BACK